Podcasts about ophthalmic consultants

Research at Boston University has led to the discovery of a non-invasive method to diagnose Alzheimer's.  This opens the door in the coming years to possibly detecting the disease in its early stages, decades before real symptoms appear.  Manju Subramanian, MD and her team found that proteins in eye fluids are providing this window to the brain. These eye fluids are confirming pathological brain conditions like dementia in the Alzheimer's form. Until now, MRIs and lumbar punctures were the tools to aid the clinical diagnosis of Alzheimer's, but that has meant late detection when the disease is already in place. Alzheimer's is not actually confirmed until after death and a post-mortem examination of the brain is done.  "We know that patients with eye disease tend to be an at-risk population for dementia. Patients with macular degeneration, glaucoma and diabetic retinopathy, those are the three big ones," says Subramanian. The potential of an eye fluid exam at an optometrist's office is ideal as it's non-invasive and not expensive.  But, it is still several years out before potentially becoming commonplace.  More research is needed. Still to be determined in future research is just how early eye fluid proteins become abnormal when dementia is developing.   "As they say, the eye is the window to the soul.  It is also very much the window to the brain," says Subramanian. ***** Manju Subramanian is an Associate Professor in Ophthalmology and Vice-Chairman of Faculty Affairs. She is an ophthalmic surgeon specializing in Vitreoretinal Disease and Surgery, and is in academic practice at Boston Medical Center. She also sees patients at the Dedham Ophthalmic Consultants. Her primary areas of clinical interest include medical and surgical management of diabetic retinopathy, age-related macular degeneration, retinal detachments, hereditary retinal diseases, ocular inflammation, and ocular trauma. Dr. Subramanian graduated from the University of Missouri School of Medicine and completed her residency at the University of Kansas Medical Center in 2002. She completed a fellowship in Vitreoretinal Disease and Surgery at Tufts University School of Medicine and Ophthalmic Consultants of Boston in 2004. Dr. Subramanian's research interests include the study of eye-based biomarkers for Alzheimer's Disease (AD), age-related macular degeneration, diabetic retinopathy, and the role of anesthesia in eye surgery. She was Principal Investigator for the first head to head clinical trial comparing the use of bevacizumab and ranibizumab in the treatment of age-related macular degeneration, and she is currently the Principal Investigator for a study assessing the role of oral sedation in eye surgery. She is also a recent recipient of an R03 Grant Award by the National Institutes of Aging as the Principal Investigator of a study looking at protein biomarkers for AD in the eye. In her role as Vice-Chairman of Faculty Affairs at Boston University Eye Associates, she works in a supportive role in the professional and career development and engagement of the clinical faculty. Prior to 2017, she served as the Vice-Chairman of Clinical Services for 8 years. She serves on several institutional committees, including the Women's Leadership Advisory Council, the Boston University Medical Group (BUMG) Research Committee, the BU School of Medicine Promotion Criteria Working Group, and also serves as Chair of the BUMG Professional Development Committee. She additionally serves on national committees, such as the International Meetings Committee for the American Academy of Ophthalmology (AAO), the Diversity Initiatives Committee for the Association for Research in Vision and Ophthalmology (ARVO), and a Special Emphasis Panel for a Study Section with the National Institutes of Health. ***** Cutting Edge Health podcast website: https://cuttingedgehealth.com/ Cutting Edge Health Social and YouTube: YouTube channel: youtube.com/@cuttingedgehealthpodcast Instagram - https://instagram.com/cuttingedgehealthpodcast Facebook - https://www.facebook.com/Cutting-Edge-Health-Podcast-with-Jane-Rogers-101036902255756 Please note that the information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Cutting Edge Health podcast, its employees, guests and affiliates assume no liability for the application of the information discussed. Special thanks to Alan, Maria, Louis, and Nicole on the Cutting Edge Health team!

An interview with Jim Sluck, Vice President at TearCare Marketing and Sharon Brown, COT, COE, Director of Operations at Ophthalmic Consultants of Boston on the topic of dry eye. This episode of EyeTalks Radio is presented by ASOA Diamond Strategic Business Partner:

About Sharon Sharon is the Director at Ophthalmic Consultants of Boston. She's been with them for over 25 years now. About Emitrr Emitrr is an Omni channel (Texting, Webchat, Missed Calls, Google My Business, and more) messaging platform for your business. Emitrr helps some of the largest brands reduce call volumes in the call center by converting calls to messages across different channels and helping grow revenue for businesses. Check us out at emitrr.com

Joining us on this Medical Monday is Dr. Robert Sax. He’s an ophthalmologist, a retinal specialist and director of Retina Services at Ophthalmic Consultants of the Capital Region . He’s here to answer your questions about everything from macular degeneration to diabetic retinopathy and retinal vein disease. WAMC's Ray Graf hosts.

On this special episode of the OIS Podcast, we’re sharing the panel discussion from our recent Gene Therapy Innovation Showcase. We have Peter Francis MD, PhD from 4D Molecular Therapeutics; Jeffrey S. Heier, MD of Ophthalmic Consultants of Boston; Arshad Khanani, MD of Sierra Eye Associates; Jose-Alain Sahel, MD, of UPMC Eye Center; and Glenn Yiu, MD, PhD, from UC Davis Health. Our panelists assess the current landscape of gene therapy and addresses how the sector is evolving to go far beyond treating only inherited retinal diseases. They discuss promising clinical trials and how the future could transform to benefit many patients outside of retina thanks to new advancements.Press play to listen in!

Treatments for some retinal conditions like age-related macular degeneration (AMD) require frequent appointments, which can be a burden for both patients and their families. On this episode of ASRS's Retina Health for Life, Dr. Jeffrey Heier of Ophthalmic Consultants of Boston joins Dr. Timothy Murray to discuss the treatment burden that many patients experience with regular eye injections and how retina specialists are striving to reduce that burden while improving patients' vision. Resources:Access a downloadable fact sheet about AMD here.Access a downloadable fact sheet about intravitreal injections here.

Listen to Chirag P. Shah, MD, MPH, for one of the most important (non-medical!) things you will learn in training: how to navigate your personal finances. Dr. Shah is a vitreoretinal surgeon at Ophthalmic Consultants of Boston, and the Co-Director of the Vitreoretinal Surgery Fellowship. He has recently co-authored a book on personal finance for physicians, “Financial Freedom Rx: The Physician's Guide to Achieving Financial Independence”, and teaches “Financial Literacy 101” at Harvard Medical School. If you are an Mass General Brigham employee, you may click here to access the webinar and handouts.

We visit again with James Thimons, OD, FAA, co-chair of OIS@SECO, the newest member of the OIS family. OIS@SECO convened last week in New Orleans, drawing more than 200 optometrists, entrepreneurs, and industry members. In this interview, Dr. Thimons, clinical director of Ophthalmic Consultants of Connecticut, walks us through the day. We also ask the dry eye expert his take on the recent fund-raising success of Oyster Pharmaceuticals, developer of a nasal spray that might help relieve the pain of that persistent condition.

Please join us Wednesday, June 14, 2017 at 4:00 p.m. PST and 7:00 p.m. EST for a live show with host Denise Messenger. Her special guest is Dr. Eric Donnenfeld. He will be discussing a new dry eye treatment. Eric Donnenfeld, MD, is a founding partner of Ophthalmic Consultants of Long Island and Connecticut.  He graduated magna cum laude from Dartmouth College in 1977 and first in his class at Dartmouth Medical School in 1980.  He was a resident and Chief Resident at Manhattan Eye, Ear and Throat Hospital and he completed a Cornea Fellowship at Wills Eye Hospital in 1985.  He is a trustee of Dartmouth Medical School and a clinical professor of ophthalmology at NYU. He has served as Resident Instructor at Manhattan Eye, Ear and Throat Hospital and as Program Director at North Shore University Hospital.  He is a National Medical Director of TLC and Surgical Director of the Lions Eye Bank for Long Island.  Dr. Donnenfeld served as president of many professional societies including the Nassau Surgical Society, cornea section of ASCRS, the Ophthalmology Division of the Nassau Academy of Medicine, and the International Ocular Microbiology and Immunology Group.  He is the past president of ASCRS and is in the presidential succession line for the International Intraocular Implant Society. Dr. Donnenfeld is the editor-in-chief of EyeWorld and the editor in chief emeritus of Cataract and Refractive Surgery Today. He has written over 190 peer review papers on cornea, external disease, cataract and refractive surgery, and 30 book chapters and books.  He is on the editorial board of 9 journals and has participated in over 60 FDA studies.  He is a Fellow of the American Academy of Ophthalmology and has received its Honor Award, Senior Honor Award, Life Time Achievement Award, and Secretariat Award. You asked for it and we deliver.

Dr. Chirag Shah of Ophthalmic Consultants of Boston rejoins the show to systematically review how he advises his graduating fellows to approach their finances as newly minted attending doctors.

Dr. Jeffrey Heier of Ophthalmic Consultants of Boston joins the show to discuss why he uses bevacizumab as his initial agent for various retinal conditions, the role of laser in his treatment of diabetic retinopathy, and more.

Dr. Chirag Shah of Ophthalmic Consultants of Boston joins the podcast to discuss his recent study evaluating Yag laser for visually significant floaters and his experience with pneumatic retinopexy.

Jeff Heier, MD, is the Director of the Vitreoretinal Service and the Director of Retina Research at Ophthalmic Consultants of Boston (OCB) gives an update from the Angiogenesis conference about the advancing anti-angiopoietin programs.

For Episode #2 of Critical Issues in Eyecare: An MD/OD Conversation, we are thrilled to have our first guest: Marguerite McDonald, MD.    Marguerite McDonald is a name familiar to almost every ophthalmologist. A pioneer in refractive surgery, in 1988 Dr McDonald performed the world’s first excimer laser surgery for myopia on a sighted eye, and then in 1993 she performed the world’s first hyperopic excimer laser treatment. She subsequently performed the first wavefront treatment excimer treatment in the Americas. A sought-after lecturer, she now practices with Ophthalmic Consultants of Long Island and holds clinical professorships at both the NYU School of Medicine in New York and Tulane University in New Orleans. The conversation includes: - The benefits of wavefront data in patient outcomes - How pre- and post- procedure evaulations differ - What does wavefront have to do with Dry Eye? - Optical Path DIfference and its utility  - The value of wavefront evaluation in patient education  - How to prioritize wavefront data - The future of wavefront in refractive surgery - And more! Please send feedback about how we can improve the show to socialmedia@marco.com! Thank you for listening! About Marco: Find out more at Marco.com, search Twitter or Facebook for MarcoOphthalmic. Join the Marco Ophthalmic Doctors Forum at https://www.facebook.com/groups/MarcoDocs/.

1)Dr. Marguerite McDonald, MD,FACS (Long Island, NY) Corneal Specialist and Cataract & Refractive Surgery at Ophthalmic Consultants of Long Island, Clinical Professor of Ophthalmology at Tulane University School of Medicine in New Orleans and senior consultant for VISX, Call: 516-593-7709 Contact Email:maligizakis@ocli.net Topic: Dr. McDonald would like to talk about dry eyes (cause, diagnosis and treatment). Please visit http://www.ocli.net/physicians/ocli-mcdonald-old.htm to learn more about Dr. McDonald. 2) John Salinas, (Grants Pass, OR) Full-time Instructor at RCC, Crater Lake Institute Board of Directors, Cascade Research Group Call: (541) 479-7351 Email: johnsalinas@charter.net Website: http://www.cascaderesearch.com , http://learn.roguecc.edu/science/jsalinas/ Topic: fresh water research and monitoring, and the several projects located in Southern Oregon

Guest: Eric D. Donnenfeld, M.D. Founding partner of Ophthalmic Consultants of Long Island  Co-Chairman of Cornea Nassau University Medical Center Long Island, NY

1)Dr. Marguerite McDonald, MD,FACS (Long Island, NY) Corneal Specialist and Cataract & Refractive Surgery at Ophthalmic Consultants of Long Island, Clinical Professor of Ophthalmology at Tulane University School of Medicine in New Orleans and senior consultant for VISX, Call: 516-593-7709 Contact Email:maligizakis@ocli.net Topic: Dr. McDonald would like to talk about dry eyes (cause, diagnosis and treatment). Please visit http://www.ocli.net/physicians/ocli-mcdonald-old.htm to learn more about Dr. McDonald. 2) John Salinas, (Grants Pass, OR) Full-time Instructor at RCC, Crater Lake Institute Board of Directors, Cascade Research Group Call: (541) 479-7351 Email: johnsalinas@charter.net Website: http://www.cascaderesearch.com , http://learn.roguecc.edu/science/jsalinas/ Topic: fresh water research and monitoring, and the several projects located in Southern Oregon

Guest: Eric D. Donnenfeld, M.D.Founding partner of Ophthalmic Consultants of Long Island Co-Chairman of CorneaNassau University Medical CenterLong Island, NY